All Stories

  1. Development, optimization and validation of an absolute specific assay for active myeloperoxidase (MPO) and its application in a clinical context: role of MPO specific activity in coronary artery disease

    Article • Clinical Chemistry and Laboratory Medicine (CCLM), February 2020, De Gruyter

    Angelina Passaro, Dr Alessandro Trentini

  2. Testing a Combination of Markers of Systemic Redox Status as a Possible Tool for the Diagnosis of Late Onset Alzheimer’s Disease

    Article • Disease Markers, September 2018, Hindawi Publishing Corporation

    Dr Alessandro Trentini, Roberta Rizzo, dr carlo cervellati, Angelina Passaro

  3. TRAIL and Ceruloplasmin Inverse Correlation as a Representative Crosstalk between Inflammation and Oxidative Stress

    Article • Mediators of Inflammation, July 2018, Hindawi Publishing Corporation

    Dr Alessandro Trentini, dr carlo cervellati, Angelina Passaro

  4. Monocyte count at onset predicts poststroke outcomes during a 90-day follow-up

    Article • European Journal of Clinical Investigation, September 2017, Wiley

    Fabrizio Montecucco, Dr Alessandro Trentini, Dr Federico Carbone

  5. Decreased serum PCSK9 levels after ischaemic stroke predict worse outcomes

    Article • European Journal of Clinical Investigation, November 2016, Wiley

    Dr Federico Carbone, Dr Alessandro Trentini, Fabrizio Montecucco

  6. Leptin/adiponectin ratio predicts poststroke neurological outcome

    Article • European Journal of Clinical Investigation, October 2015, Wiley

    Dr Alessandro Trentini, Dr Federico Carbone

  7. serum paraoxonase in alzheimer and MCI

    Article • Journal of Neurochemistry, August 2015, Wiley

    Dr Alessandro Trentini, dr carlo cervellati, Angelina Passaro

  8. Cerebrospinal fluid amounts of HLA-G in dimeric form are strongly associated to patients with MRI inactive multiple sclerosis

    Article • Multiple Sclerosis Journal, June 2015, SAGE Publications

    Dr Alessandro Trentini

  9. Serum osteopontin levels are upregulated and predict disability after an ischaemic stroke

    Article • European Journal of Clinical Investigation, April 2015, Wiley

    Dr Alessandro Trentini, Dr Federico Carbone, Fabrizio Montecucco

  10. TIMP-1 resistant matrix metalloproteinase-9 is the predominant serum active isoform associated with MRI activity in patients with multiple sclerosis

    Article • Multiple Sclerosis Journal, February 2015, SAGE Publications

    Dr Alessandro Trentini

  11. Treatment with recombinant tissue plasminogen activator (r-TPA) induces neutrophil degranulation in vitro via defined pathways

    Article • Vascular Pharmacology, January 2015, Elsevier

    Dr Alessandro Trentini, Dr Federico Carbone

  12. N-Acetylaspartate and neurofilaments as biomarkers of axonal damage in patients with progressive forms of multiple sclerosis

    Article • Deutsche Zeitschrift für Nervenheilkunde, September 2014, Springer Science + Business Media

    Dr Alessandro Trentini

  13. Balanced and unbalanced solutions modulate the release of Matrix Metalloproteinase-9 (MMP-9) from neutrophils in response to inflammatory stimuli: an in vitro study

    Article • Inflammation Research, January 2014, Springer Science + Business Media

    Dr Alessandro Trentini

  14. Matrix metalloproteinase-2 (MMP-2) generates soluble HLA-G1 by cell surface proteolytic shedding

    Article • Molecular and Cellular Biochemistry, June 2013, Springer Science + Business Media

    Dr Alessandro Trentini

  15. Effects of two different strategies of fluid administration on inflammatory mediators, plasma electrolytes and acid/base disorders in patients undergoing major abdominal surgery: a randomized double blind study

    Article • Journal of Inflammation, January 2013, Springer Science + Business Media

    Dr Alessandro Trentini

  16. CSF neurofilament and N-acetylaspartate related brain changes in clinically isolated syndrome

    Article • Multiple Sclerosis Journal, August 2012, SAGE Publications

    Dr Stefan Ropele, Dr Alessandro Trentini

  17. Matrix metalloproteinase-9 activity detected in body fluids is the result of two different enzyme forms

    Article • The Journal of Biochemistry, February 2012, Oxford University Press (OUP)

    Dr Alessandro Trentini

  18. Identification of biomarkers for diagnosis and progression of MS by MALDI-TOF mass spectrometry

    Article • Multiple Sclerosis Journal, April 2011, SAGE Publications

    Dr Alessandro Trentini

  19. Timing of Serum Active MMP-9 and MMP-2 Levels in Acute and Subacute Phases After Spontaneous Intracerebral Hemorrhage

    Article • August 2009, Springer Science + Business Media

    Dr Alessandro Trentini

  20. Potential relevance of cerebrospinal fluid and serum levels and intrathecal synthesis of active matrix metalloproteinase-2 (MMP-2) as markers of disease remission in patients with multiple sclerosis

    Article • Multiple Sclerosis Journal, March 2009, SAGE Publications

    Dr Alessandro Trentini